Pharming Group (PHAR)
9.15
+0.22
(+2.46%)
USD |
NASDAQ |
May 31, 16:00
9.105
-0.04
(-0.49%)
After-Hours: 20:00
Pharming Group Cash from Investing (Quarterly): 0.664M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.664M |
| December 31, 2023 | -3.908M |
| September 30, 2023 | -145.57M |
| June 30, 2023 | 20.31M |
| March 31, 2023 | -0.215M |
| December 31, 2022 | -0.399M |
| September 30, 2022 | -0.298M |
| June 30, 2022 | 6.395M |
| March 31, 2022 | -0.375M |
| December 31, 2021 | -6.128M |
| September 30, 2021 | -7.452M |
| June 30, 2021 | -5.16M |
| March 31, 2021 | -2.565M |
| December 31, 2020 | -3.706M |
| September 30, 2020 | -1.556M |
| June 30, 2020 | -3.440M |
| March 31, 2020 | -6.926M |
| December 31, 2019 | -3.356M |
| September 30, 2019 | -20.08M |
| June 30, 2019 | -4.436M |
| March 31, 2019 | -0.3852M |
| December 31, 2018 | 0.2006M |
| September 30, 2018 | -2.183M |
| June 30, 2018 | -1.256M |
| March 31, 2018 | -1.073M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.725M |
| September 30, 2017 | -3.176M |
| June 30, 2017 | -1.460M |
| March 31, 2017 | -0.8912M |
| December 31, 2016 | -59.41M |
| September 30, 2016 | -0.1979M |
| June 30, 2016 | -0.5645M |
| March 31, 2016 | -0.272M |
| December 31, 2015 | -0.2347M |
| September 30, 2015 | -0.2918M |
| June 30, 2015 | -0.3958M |
| March 31, 2015 | -0.0596M |
| December 31, 2014 | -0.1608M |
| September 30, 2014 | -0.6345M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.0076M |
| September 30, 2013 | 0.0117M |
| June 30, 2013 | -0.022M |
| March 31, 2013 | 0.3355M |
| December 31, 2012 | 0.0029M |
| September 30, 2012 | 0.8666M |
| June 30, 2012 | -0.5653M |
| March 31, 2012 | -0.1614M |
| December 31, 2011 | -0.5403M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-145.57M
Minimum
Sep 2023
20.31M
Maximum
Jun 2023
-9.410M
Average
-3.398M
Median
Cash from Investing (Quarterly) Benchmarks
| uniQure NV | 63.98M |
| ProQR Therapeutics NV | -19.26M |
| Merus NV | -12.08M |
| argenx SE | -- |
| Pharvaris NV | -0.0334M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.647M |
| Cash from Financing (Quarterly) | -2.471M |
| Free Cash Flow | -3.493M |
| Free Cash Flow Per Share (Quarterly) | -0.1179 |
| Free Cash Flow to Equity (Quarterly) | -4.194M |
| Free Cash Flow to Firm (Quarterly) | -7.727M |
| Free Cash Flow Yield | -0.52% |